Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document
 Download Current HansardDownload Current Hansard    View Or Save XMLView/Save XML

Previous Fragment    
Wednesday, 15 August 2012
Page: 8852

Health

(Question No. 1118)


Mr Dutton asked the Minister for Health, in writing, on 28 June 2012:

In respect of the introduction of the Diagnostic Imaging Accreditation Scheme (the Scheme), (a) were any changes to the Scheme undertaken as a result of the evaluation of Phase 1; if so, what were these changes, and (b) will her department undertake an evaluation of Phase 2 of the Scheme; if so, (i) what will be considered as part of the review, (ii) will the Royal Australian and New Zealand College of Obstetricians and Gynaecologists and the National Association of Specialist Obstetricians and Gynaecologists be consulted as part of the evaluation, (iii) will the evaluation consider the cost impact of the Scheme on small and single practitioner non-radiology practices, (iv) will the evaluation include a review of the impact on clinical outcomes of the Scheme in small and single practitioner non-radiology practices, (v) has there been, or will there be, as part of the evaluation, consideration of the exclusion of non-referred Medical Benefits Scheme items from the Scheme, (vi) when will the evaluation commence, and (vii) on what date will the findings of the evaluation of Phase 2 be released.


Ms Plibersek: The answer to the honourable member's question is as follows:

(a) No.

(b) Yes.

(i) The second phase of the review will evaluate the impact of the requirement for practices to comply with the full suite of practice accreditation standards and will help to identify any concerns raised by diagnostic imaging practices in complying with the additional standards.

(ii) The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) and the National Association of Specialist Obstetricians and Gynaecologists will continue to be consulted as part of the evaluation. In Phase 1, an Expert Working Group, comprising around 15 members including a representative from RANZCOG was convened to assist the department prepare the standards for the Scheme.

(iii) The evaluation will consider the cost impact of the Scheme on all practices, including small and single practitioner non-radiology practices, as well as the benefits the application of common, measurable safety and quality standards has for patients.

(iv) Yes.

(v) The appropriate arrangements for non-referred ultrasound services under the Medicare Benefits Schedule will be considered.

(vi) The evaluation of Stage 2 will commence in July 2012.

(vii) The findings of the evaluation will be available by the end of 2013, after which detailed consideration will be given to any recommendations that come from the review.